Superpotent Drug: products were found to be contaminated and above specification for lidocaine assay.
Drugs Recalls
Prescription and over-the-counter medications
Failed Impurities/Degradation Specifications
Failed Impurities/Degradation Specifications
Failed Impurities/Degradation Specifications
Failed Impurities/Degradation Specifications: High Out Of Specification results for impurities detected during routine stability testing.
Failed Impurities/Degradation Specifications
Failed Impurities/Degradation Specifications
Microbial Contamination of Non-Sterile Products: products were found to be contaminated and above specification for lidocaine assay.
Failed Impurities/Degradation Specifications
Failed Impurities/Degradation Specifications
Failed Impurities/Degradation Specifications
Superpotent Drug: products were found to be contaminated and above specification for lidocaine assay.
Failed Impurities/Degradation Specifications
Superpotent Drug: products were found to be contaminated and above specification for lidocaine assay.
Failed Impurities/Degradation Specifications
Failed Impurities/Degradation Specifications
Superpotent Drug: products were found to be contaminated and above specification for lidocaine assay.
Bevacizumab, 2.5 mg/0.1 mL, Norm-Ject Syringe Intravitreal Injection, Single use only, Rx only, Repackaged by AmEx Pharmacy 1515 Elizabeth St. Suite J Melbourne, FL 32901
Pacifico National, Inc.
Lack of assurance of sterility.
Gatifloxacin Ophthalmic Solution 0.5%, 2.5 mL per bottle, Rx Only, Mfd. for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505. Made in India. NDC: 0378-5431-35
Mylan Pharmaceuticals
Failed Impurities/Degradation Specifications:OOS for unknown impurity.
Subpotent Drug: Out of specification result during stability study in Pramipexole Dihydrochloride Tablets 0.125 mg